Analytical Data
-
Gene name
SNX20
- Application
-
Alternative Names
Selectin ligand-interactor Cytoplasmic domain 1
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z614
-
Expression Region
1-102aa
-
Molecular Weight
38.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SNX20 protein, part of the sorting nexin family, plays a crucial role in cellular trafficking and membrane dynamics. Its study has gained significance due to its involvement in various cellular processes, including endosomal recycling and signal transduction. Abnormalities in SNX20 function have been linked to several diseases, particularly those affecting the nervous system, such as neurodegenerative disorders. Researchers are particularly interested in isolating and characterizing recombinant SNX20 proteins to elucidate their structural and functional properties. Through recombinant protein technology, scientists can produce SNX20 in a controlled environment, allowing for detailed studies of its interactions with other cellular components and its role in cellular pathways. Understanding the mechanism of SNX20 is expected to provide insights into its biological functions and potential therapeutic targets for diseases associated with its dysfunction. Experimental approaches including biophysical characterization, localization studies, and functional assays are being employed to uncover the intricacies of SNX20's involvement in cellular processes. This research not only contributes to the fundamental understanding of sorting nexins but also opens avenues for developing targeted interventions in diseases linked to SNX20 malfunction.
